Skip to main content
. Author manuscript; available in PMC: 2023 Jan 10.
Published in final edited form as: Nat Med. 2022 Jan 10;28(1):144–153. doi: 10.1038/s41591-021-01600-6

Extended Data Fig. 2. Forest plot of known biomarkers in urothelial carcinoma, renal cell carcinoma and prostate cancer.

Extended Data Fig. 2

Biomarkers shown among urothelial carcinoma (IMvigor210), renal cell carcinoma (IMmotion150), and prostate cancer (IMbassador250) for PFS. DDR, DNA damage response; PD-L1, programmed death- ligand 1; PFS, progression-free survival; Teff, effector T cell, TMB, tumour mutational burden. Med refers to median PFS in months. HRs and CIs were calculated using Cox proportional hazards regression model, and P values were calculated using unstratified log-rank test without adjustment for multiplicity.